Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04871347
Status:
UNKNOWN
Last Update Posted:
2021-07-27
First Post:
2021-04-29
Brief Title:
The Safety and Efficacy of TWP-101 in Patients With Advanced Solid Tumor
Sponsor:
Shandong TheraWisdom Biopharma Co Ltd
Organization:
Shandong TheraWisdom Biopharma Co Ltd
Study Overview
Official Title:
A Multi-center Phase IaIb Open Clinical Study to Evaluate the Safety and Efficacy of TWP-101 in Patients With Advanced Solid Tumor
Status:
UNKNOWN
Status Verified Date:
2021-05
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multi-center phase IaIb open clinical study to evaluate the safety and efficacy of TWP-101 in patients with advanced solid tumor This study consists of two parts Part A and Part B Part A was a dose escalation study and Part B was a dose expansion study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None